Abstract
A standardized enzyme-linked immunosorbent assay (ELISA), performed directly on monolayers of mouse peritoneal macrophages or L 929 fibroblasts, was used to evaluate the activity of chemotherapeutic agents against four different stocks of Trypanosoma cruzi. Absorbance readings, performed in an automatic ELISA reader, were directly related to the number of intracellular parasites as determined by microscopic examination of tissue culture slides run in parallel. Results were highly reproducible in replicate wells and in repeated experiments. Results with nifurtimox, ketoconazole, and formycin B, compounds known to have in vivo activity against T. cruzi, revealed that the ELISA technique was capable of detecting small dose-response variations in the rate of phagocytosis of different life cycle stages of T. cruzi by normal and activated mouse macrophages.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: The American Journal of Tropical Medicine and Hygiene
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
